A carregar...
Fidaxomicin Use and Clinical Outcomes for Clostridium difficile–Associated Diarrhea
BACKGROUND: Fidaxomicin has been scrutinized because of its high acquisition cost. Real-world experience is needed to determine whether fidaxomicin has value in patients with Clostridium difficile–associated diarrhea (CDAD) and certain risk factors. METHODS: In this single-center, retrospective coho...
Na minha lista:
| Publicado no: | Infect Dis Clin Pract (Baltim Md) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4280276/ https://ncbi.nlm.nih.gov/pubmed/25574116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IPC.0000000000000181 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|